Page last updated: 2024-12-07

valinol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

valinol: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID79019
CHEBI ID183239
SCHEMBL ID142192
MeSH IDM0121754

Synonyms (61)

Synonym
CHEBI:183239
473-75-6
2-amino-3-methylbutan-1-ol
1-butanol, 2-amino-3-methyl-
1-butanol, 2-amino-3-methyl-,
nsc322922
1-butanol, 2-amino-3-methyl-, (.+/-.)-
2-amino-3-methyl-1-butanol, 97%
valinol
dl-valinol
2-amino-3-methyl-1-butanol
16369-05-4
V0100
AKOS009156893
A828085
2-azanyl-3-methyl-butan-1-ol
unii-r54n4nj3zz
nsc 322922
l-2-amino-3-methylbutan-1-ol
einecs 217-975-5
h-valinol
f4fx82atu2 ,
unii-f4fx82atu2
valinol, dl-
einecs 240-425-0
(1)-2-amino-3-methylbutan-1-ol
FT-0605176
FT-0627611
FT-0625633
AM20080457
SCHEMBL142192
SY006320
SY006455
mfcd00004730
SY003828
2-amino-3-methyl-butan-1-ol
(dl)-valinol
(.+/-.)-2-amino-3-methyl-1-butanol
dimethyldioctylammoniumbromide
CS-W004906
r-|a inverted exclamation mark-lipoic acid
J-010075
dl-2-amino-3-methyl-1-butanol
F1564-0026
FT-0708252
AS-10338
Q7911716
(+/-)-valinol
DTXSID70862814
h-d-val-ol
d/l-valinol
PB47612
EN300-74424
1-butanol, 2-amino-3-methyl-, (+/-)-
2-amino-3-methylbutanol
n-(1-hydroxy-3-methylbutan-2-yl)amine
(1-(hydroxymethyl)-2-methylpropyl)amine
3-methyl-2-aminobutanol
1-butanol, 2-amino-3-methyl-, dl-
(+/-)-2-amino-3-methyl-1-butanol
rac-valinol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
amino alcoholAn alcohol containing an amino functional group in addition to the alcohol-defining hydroxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (23.08)18.7374
1990's0 (0.00)18.2507
2000's7 (53.85)29.6817
2010's3 (23.08)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.60 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.13 (4.65)
Search Engine Demand Index44.36 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]